76 related articles for article (PubMed ID: 22261253)
1. ErbB3(80 kDa), a nuclear variant of the ErbB3 receptor, binds to the Cyclin D1 promoter to activate cell proliferation but is negatively controlled by p14ARF.
Andrique L; Fauvin D; El Maassarani M; Colasson H; Vannier B; Séité P
Cell Signal; 2012 May; 24(5):1074-85. PubMed ID: 22261253
[TBL] [Abstract][Full Text] [Related]
2. Nuclear epidermal growth factor receptor interacts with transcriptional intermediary factor 2 to activate cyclin D1 gene expression triggered by the oncoprotein latent membrane protein 1.
Shi Y; Tao Y; Jiang Y; Xu Y; Yan B; Chen X; Xiao L; Cao Y
Carcinogenesis; 2012 Aug; 33(8):1468-78. PubMed ID: 22581837
[TBL] [Abstract][Full Text] [Related]
3. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
[TBL] [Abstract][Full Text] [Related]
4. BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.
Nakuci E; Mahner S; Direnzo J; ElShamy WM
Exp Cell Res; 2006 Oct; 312(16):3120-31. PubMed ID: 16860316
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
Bartusel T; Schubert S; Klempnauer KH
Gene; 2005 May; 351():171-80. PubMed ID: 15922873
[TBL] [Abstract][Full Text] [Related]
6. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
Yang C; Klein EA; Assoian RK; Kazanietz MG
Biochem J; 2008 Feb; 410(1):167-75. PubMed ID: 17941827
[TBL] [Abstract][Full Text] [Related]
7. A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines.
Crowe DL; Brown TN; Kim R; Smith SM; Lee MK
Mol Cell Biol Res Commun; 2000 Apr; 3(4):243-8. PubMed ID: 10891399
[TBL] [Abstract][Full Text] [Related]
8. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.
Faivre E; Skildum A; Pierson-Mullany L; Lange CA
Steroids; 2005; 70(5-7):418-26. PubMed ID: 15862825
[TBL] [Abstract][Full Text] [Related]
9. Ligand-dependent activation of the chimeric tumor necrosis factor receptor-amyloid precursor protein (APP) reveals increased APP processing and suppressed neuronal differentiation.
Sim PL; Heese K
Neurosignals; 2010; 18(1):9-23. PubMed ID: 19786811
[TBL] [Abstract][Full Text] [Related]
10. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.
Balasenthil S; Barnes CJ; Rayala SK; Kumar R
FEBS Lett; 2004 Jun; 567(2-3):243-7. PubMed ID: 15178330
[TBL] [Abstract][Full Text] [Related]
12. Bombesin regulates cyclin D1 expression through the early growth response protein Egr-1 in prostate cancer cells.
Xiao D; Chinnappan D; Pestell R; Albanese C; Weber HC
Cancer Res; 2005 Nov; 65(21):9934-42. PubMed ID: 16267018
[TBL] [Abstract][Full Text] [Related]
13. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M
Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919
[TBL] [Abstract][Full Text] [Related]
14. Atypical expression of ErbB3 in myeloma cells: cross-talk between ErbB3 and the interferon-alpha signaling complex.
Walters DK; French JD; Arendt BK; Jelinek DF
Oncogene; 2003 Jun; 22(23):3598-607. PubMed ID: 12789268
[TBL] [Abstract][Full Text] [Related]
15. Integrated and Functional Genomics Analysis Validates the Relevance of the Nuclear Variant ErbB380kDa in Prostate Cancer Progression.
El Maassarani M; Barbarin A; Fromont G; Kaissi O; Lebbe M; Vannier B; Moussa A; Séité P
PLoS One; 2016; 11(5):e0155950. PubMed ID: 27191720
[TBL] [Abstract][Full Text] [Related]
16. p14ARF post-transcriptional regulation of nuclear cyclin D1 in MCF-7 breast cancer cells: discrimination between a good and bad prognosis?
McGowan EM; Tran N; Alling N; Yagoub D; Sedger LM; Martiniello-Wilks R
PLoS One; 2012; 7(7):e42246. PubMed ID: 22860097
[TBL] [Abstract][Full Text] [Related]
17. PAK1-Nck regulates cyclin D1 promoter activity in response to prolactin.
Tao J; Oladimeji P; Rider L; Diakonova M
Mol Endocrinol; 2011 Sep; 25(9):1565-78. PubMed ID: 21719533
[TBL] [Abstract][Full Text] [Related]
18. Activation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas.
Kobayashi M; Iwamatsu A; Shinohara-Kanda A; Ihara S; Fukui Y
Oncogene; 2003 Mar; 22(9):1294-301. PubMed ID: 12618754
[TBL] [Abstract][Full Text] [Related]
19. Mapping C-terminal transactivation domains of the nuclear HER family receptor tyrosine kinase HER3.
Brand TM; Iida M; Luthar N; Wleklinski MJ; Starr MM; Wheeler DL
PLoS One; 2013; 8(8):e71518. PubMed ID: 23951180
[TBL] [Abstract][Full Text] [Related]
20. RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus.
Huo L; Wang YN; Xia W; Hsu SC; Lai CC; Li LY; Chang WC; Wang Y; Hsu MC; Yu YL; Huang TH; Ding Q; Chen CH; Tsai CH; Hung MC
Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16125-30. PubMed ID: 20802156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
